CNBC's Meg Tirrell reports on Mylan's decision to launch a generic EpiPen as a way of cutting the cost of the treatment.
Amid Mylan launching an EpiPen generic alternative, the “Fast Money Halftime Report” traders and CNBC’s Jim Cramer share their take on Mylan and the biotech sector.
There's a case for applying laws against profiteering to the drug industry, Dr. Joshua Sharfstein tells CNBC.
Bill Ackman tells CNBC the past 12 months were the "worst period of performance" of his career, and the implosion of Valeant Pharmaceuticals was mostly to blame.
CNBC’s Meg Tirrell reports the latest on Mylan prices and the drug price blame game.
Chris Kofinis, a Democratic strategist - who worked for Mylan CEO Heather Bresch's father, Sen. Joe Manchin - criticizes her response to the EpiPen "crisis."
Rep. Lloyd Doggett (D-Texas) discusses the EpiPen pricing saga and his views on greater price gouging in the drug industry with the "Fast Money" traders.
CNBC's Meg Tirrell reports the latest on the drug price debate, Teva on a generic EpiPen and the FDA. David Maris, Wells Fargo analyst, and the "FMHR" traders weigh in.
The "FMHR" panel and David Maris, specialty pharmaceutical analyst at Wells Fargo Securities, discuss the latest on the EpiPen pricing outrage.
Mylan's decision to "gouge" consumers on lifesaving EpiPen devices is corporate "greed on steroids," consumer advocate Ralph Nader tells CNBC.
Mylan CEO Heather Bresch speaks to CNBC on Thursday about the controversy surrounding her company's 400-percent price hike to EpiPens over the past few years.
Colombia's government and leftist FARC rebels unveiled a peace deal to end a guerrilla war which almost made the country a failed state.
Some people are decrying Duterte's drugs crackdown and the casualties while others are in support of it, says Teneo Holdings' Roberto Herrera-Lim.
De La Salle University's Richard Heydarian says the Philippines' president is under pressure to deliver on promises to be tough on crime and shake-up bureaucracy.
Clovis Oncology shares shot up more than 26 percent Tuesday after the FDA accepted the company's new drug application.
CNBC's Meg Tirrell reports the details on Pfizer's deal for Medivation.
Philippine President Rodrigo Duterte railed against the United Nations after it called for an end to the wave of killings unleashed by his war on drugs.
NEW YORK, Aug 17- Two former Insys Therapeutics Inc employees pleaded not guilty on Wednesday to charges that they engaged in a scheme to pay doctors kickbacks including speaker fees to prescribe a drug containing the opioid fentanyl. Jonathan Roper, a former Insys district sales manager, and Fernando Serrano, a former sales representative, entered their pleas...
Morgan Stanley upgraded Valeant Pharmaceuticals to overweight from equal weight.
WASHINGTON/ NEW YORK, Aug 11- The U.S. Drug Enforcement Administration on Thursday denied requests to stop classifying marijuana as a dangerous drug with no medical use, leaving users and businesses in limbo after many states have legalized it for medical or recreational purposes. Representative Earl Blumenauer, a Democrat from Oregon, said in a statement.